• MDB Direct
  • Community Portal
  • Submit Your Big Idea
MDB Capital
  • Why Public Venture?
    • What is Public Venture?
    • Public Venture Advantage
    • How to Invest
    • MDB Outcomes
  • Why MDB?
    • MDB Difference
    • Investment Criteria
    • Curation Process
    • Outcomes
    • Launch Capabilities
    • MDB Capital Brokerage
    • Community
      • Membership Group
      • Member Criteria & Benefits
  • MDB Direct
    • Overview
    • MDB Direct
    • IRAs
    • Open an Account
  • Media
    • Videos
    • Press Releases
    • Articles
    • Reports
  • About
    • Overview
    • Our Platform
    • Value Creation
    • Join Us
    • Contact
    • Leadership Team
    • Submit Big Idea
  • MDBH Investors
    • Overview
    • Press Releases
    • SEC Filings
    • Stock Info
    • Governance
    • Email Alerts
    • IR Contact
    • Events
Select Page

MDB Capital/Media

Videos

MDB Capital and the companies it backs make the news because of their revolutionary approaches to solving global challenges. If you have needs beyond these resources, please contact [email protected]

04.24.2025

Chris Marlett Joins the Venture Studio Forum Speakers Series Podcast

03.31.2025

MDB Capital Holdings Fourth Quarter and Full Year 2024 Results Call

11.21.2024

MDB Capital Holdings Third Quarter 2024 Results Webinar

10.21.2024

MDB Vested Interests – Episode 9 – Traditional Venture vs. Public Venture

09.12.2024

MDB Vested Interests – Episode 8: ClearSign Technologies CEO Dr. Jim Deller

09.11.2024

Invizyne IPO Update Call

07.29.2024

Invizyne IPO – Conversation with Zachary Karl, Ph.D., VP Business Development

07.26.2024

MDB Vested Interests – Episode 7- Invizyne Technologies Business Development with Zachary Karl

07.26.2024

MDB Vested Interests – Episode 6 – Advancing Clean Tech to Energize the Future

07.26.2024

National Renewable Energy Lab (NREL) working with Invizyne

07.17.2024

Invizyne IPO – KOL Call with Dr. James J. Lalonde

07.17.2024

MDB Vested Interests – Episode 5: Understanding Cell Free Biomanufacturing in Synthetic Biology

Up Next | Press Releases >
Join Mailing List

Terms of Use  |  Governance  |  Business Continuity  |  Member FINRA/SIPC  |  FINRA’s BrokerCheck  |  Disclosures
© 2025 MDB Capital

Stay Informed

Receive the latest information, insights and news from MDB Capital.

×